NICOLE MUNSHOWER: Open Payments
NPI 1497161954 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 27 payments from 12 companies in 2025. Trend: 2023 $395 · 2024 $596 · 2025 $1,463
Travel & lodging: $754Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 9 | $1,133 |
| Bioventus LLC | 3 | $68 |
| Abbott Laboratories | 3 | $59 |
| Novo Nordisk Inc | 2 | $43 |
| Fidia Pharma USA Inc. | 2 | $33 |
| Dexcom, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Iovera, XCELL, FREESTYLE LIBRE 3, TRILURON, Dexcom G6 Transmitter, EXOGEN ULTRASOUND BONE HEALING SYSTEM, Ozempic, PROCLAIM.
Industry payments across VA — which companies pay providers there.
